King Legacy, a wholly owned subsidiary of Pfizer
King Legacy, a wholly owned subsidiary of Pfizer appears in FDA public data with 11 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-430-2013, Class II) was initiated on April 30, 2013.
Summary
- Total Recalls
- 11
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-430-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-85 | April 30, 2013 |
| D-422-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851 | April 30, 2013 |
| D-428-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-85 | April 30, 2013 |
| D-426-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-85 | April 30, 2013 |
| D-431-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-86 | April 30, 2013 |
| D-423-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852 | April 30, 2013 |
| D-421-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850 | April 30, 2013 |
| D-424-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853 | April 30, 2013 |
| D-429-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-85 | April 30, 2013 |
| D-425-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-85 | April 30, 2013 |
| D-427-2013 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-85 | April 30, 2013 |